Case report: Confirming a diagnosis of severe olmesartan-associated enteropathy*

Elsevier

Available online 24 June 2022

TherapiesKeywords

Olmesartan

Angiotensin II receptor blocker

Sprue-like enteropathy

Hospitalisation

Rechallenge

View full text

© 2022 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.

留言 (0)

沒有登入
gif